4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-17-001636
EVP AND GC sold 37,500 shares at $40.91 ($1,534,043)
- EVP AND GC acquired 39,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Baity Glenn EVP AND GC | 2017-10-04 | Option exercise | +6,500 | $1.62 | $10,530 | 74,156 | D |
| Baity Glenn EVP AND GC | 2017-10-04 | Option exercise | +4,500 | $2.18 | $9,810 | 78,656 | D |
| Baity Glenn EVP AND GC | 2017-10-05 | Option exercise | +1,000 | $2.18 | $2,180 | 79,656 | D |
| Baity Glenn EVP AND GC | 2017-10-05 | Option exercise | +7,500 | $1.62 | $12,150 | 99,656 | D |
| Baity Glenn EVP AND GC | 2017-10-05 | Option exercise | +20,000 | $2.00 | $40,000 | 107,156 | D |
| Baity Glenn EVP AND GC | 2017-10-05 | Sale | −37,500 | $40.91 | $1,534,043 | 69,656 | D |
| Derivatives | |||||||
| Baity Glenn EVP AND GC | 2017-10-04 | Option exercise · Stock Option (right to buy) | −6,500 | 7,500 | D | ||
| Baity Glenn EVP AND GC | 2017-10-04 | Option exercise · Stock Option (right to buy) | −4,500 | 125,500 | D | ||
| Baity Glenn EVP AND GC | 2017-10-05 | Option exercise · Stock Option (right to buy) | −1,000 | 124,500 | D | ||
| Baity Glenn EVP AND GC | 2017-10-05 | Option exercise · Stock Option (right to buy) | −7,500 | 0 | D | ||
| Baity Glenn EVP AND GC | 2017-10-05 | Option exercise · Stock Option (right to buy) | −20,000 | 0 | D | ||
| Open-market sales · 37,500 sh · avg $40.91 · $1,534,043 | |||||||
Loading xslF345X03/form4-10062017_031038.xml…